Osteoporosis in men and women

https://doi.org/10.1016/S1098-3597(06)80063-3Get rights and content

Osteoporosis is a cause of significant morbidity and mortality in postmenopausal women as well as men. In both men and women, increasing age and low bone mineral density (BMD) are the 2 most important independent risk factors for an initial vertebral or nonvertebral fracture. Although the prevalence of osteoporosis is greater in women, mortality after fracture is higher among men.

In both men and women, the incidence of vertebral fracture increases with age, although the increase is more marked in women than in men. The diagnostic criteria for postmenopausal osteoporosis in women are well established; however, there is ongoing debate about the appropriate T-scores and BMD thresholds to diagnose osteoporosis in men.

Alendronate and risedronate are considered first-line therapy for the treatment of both postmenopausal osteoporosis and male osteoporosis. The efficacy and safety of these agents have been evaluated extensively in randomized clinical trials. Studies suggest that these agents are similarly efficacious in men and women. The anabolic agent teriparatide may also be used to treat men with osteoporosis at high risk for fracture. Studies suggest that treatment with an anabolic agent like teriparatide should be followed by an antiresorptive agent.

References (47)

  • National Osteoporosis Foundation

    Fast facts

    (2006)
  • CampionJ.M. et al.

    Osteoporosis in men

    Am Fam Phys

    (2003)
  • KamelH.K.

    Male osteoporosis: New trends in diagnosis and therapy

    Drugs Aging

    (2005)
  • van der KliftM. et al.

    The incidence of vertebral fractures in men and women: The Rotterdam Study

    J Bone Miner Res

    (2002)
  • MarshallD. et al.

    Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

    BMJ

    (1996)
  • van der KliftM. et al.

    Risk factors for incident vertebral fractures in men and women: The Rotterdam Study

    J Bone Miner Res

    (2004)
  • KlotzbuecherC.M. et al.

    Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis

    J Bone Miner Res

    (2000)
  • Goderie-PlompH.W. et al.

    Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: The Rotterdam Study

    J Clin Endocrinol Metab

    (2004)
  • World Health Organization

    Prevention and management of osteoporosis

    WHO Technical Report series 921

    (2006)
  • US Preventive Services Task Force

    Screening for Osteoporosis in Postmenopausal Women: Recommendations and Rationale

    (September 2002)
  • National Osteoporosis Foundation

    Physician's Guide to Prevention and Treatment of Osteoporosis

    (2003)
  • AACE

    American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 Edition, with selected updates for 2003

    Endocr Prac

    (2003)
  • Management of osteoporosis in postmenopausal women

    2006 Position statement of the North American Menopause Society

    Menopause

    (2006)
  • Cited by (0)

    View full text